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Abstract
Multicompartment diffusion magnetic resonance imaging (MRI) approaches are
increasingly being applied to estimate intra-axonal and extra-axonal diffusion charac-
teristics in the human brain. Fiber ball imaging (FBI) and its extension fiber ball white
matter modeling (FBWM) are such recently described multicompartment approaches.
However, these particular approaches have yet to be applied in clinical cohorts. The
modeling of several diffusion parameters with interpretable biological meaning may
offer the development of new, noninvasive biomarkers of pharmacoresistance in epi-
lepsy. In the present study, we used FBI and FBWM to evaluate intra-axonal and
extra-axonal diffusion properties of white matter tracts in patients with longstanding
focal epilepsy. FBI/FBWM diffusion parameters were calculated along the length of
50 white matter tract bundles and statistically compared between patients with
refractory epilepsy, nonrefractory epilepsy and controls. We report that patients with
chronic epilepsy had a widespread distribution of extra-axonal diffusivity relative to
controls, particularly in circumscribed regions along white matter tracts projecting to
cerebral cortex from thalamic, striatal, brainstem, and peduncular regions. Patients
with refractory epilepsy had significantly greater markers of extra-axonal diffusivity
compared to those with nonrefractory epilepsy. The extra-axonal diffusivity alter-
ations in patients with epilepsy observed in the present study could be markers of
neuroinflammatory processes or a reflection of reduced axonal density, both of
which have been histologically demonstrated in focal epilepsy. FBI is a clinically feasi-
ble MRI approach that provides the basis for more interpretive conclusions about the
microstructural environment of the brain and may represent a unique biomarker of
pharmacoresistance in epilepsy.
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1 | INTRODUCTION
Despite being classically considered to be a gray matter disorder,
increasing evidence demonstrates cerebral white matter pathology in
focal epilepsy. Epilepsy is a systems network brain disorder and is
characterized by various neuropathological processes in the cerebral
white matter, both in lesional and nonlesional cases (Concha, Livy,
Beaulieu, Wheatley, & Gross, 2010; Deleo et al., 2018; Reeves
et al., 2016). Identifying and characterizing these changes using nonin-
vasive imaging techniques are important as this will provide deeper
insights into the mechanisms of pathology in individual patients and
potentially inform clinical and surgical decision-making. For example,
reconstruction of white matter structural networks and connectivity
using diffusion MRI (dMRI) has been demonstrated to be an effective
imaging biomarker of postoperative outcome in focal epilepsy
(Bonilha et al., 2013; Bonilha, Jensen, et al., 2015; Keller et al., 2015;
Keller et al., 2017). Diffusion tensor imaging (DTI) and extensions of
which, such as diffusion kurtosis imaging (DKI), have been widely used
to study white matter alterations in patients with focal epilepsy. Typi-
cal findings show a pattern of reduced fractional anisotropy (FA) and
increased mean diffusivity (MD) in patients with focal epilepsy
(Concha, Beaulieu, & Gross, 2005; Gross, Concha, & Beaulieu, 2006;
McDonald et al., 2008), and a more widespread pattern of altered kur-
tosis metrics, suggesting an increased sensitivity of DKI in detecting
WM abnormalities in epilepsy (Bonilha, Lee, et al., 2015; Glenn
et al., 2016; Lee et al., 2014). However, while both DTI and DKI are
reasonably sensitive to changes in white matter microstructure, these
parameters only describe the tissue environment in terms of diffusion
physics, rather than in biological parameters. They therefore lack
microstructural specificity, making biological interpretation difficult
(Fieremans, Jensen, & Helpern, 2011). To overcome this limitation,
several diffusion methods have been proposed that more directly
relate parameters with clear biological meanings to the diffusion MRI
signal (Jelescu & Budde, 2017; Novikov, Kiselev, & Jespersen, 2018).
These must necessarily introduce assumptions and approximations
that explicitly connect water diffusion to microstructure. The simplest
of such methods are based on the assumption that there are two non-
exchanging water compartments within brain white matter: a fast
(which models the less hindered extra-axonal water) and a slow (which
models the more restricted intra-axonal water) diffusion compartment
(Assaf, Freidlin, Rohde, & Basser, 2004; Fieremans et al., 2011;
Kleban, Tax, Rudrapatna, Jones, & Bowtell, 2020).
The recently developed fiber ball imaging (FBI) is one such two-
compartment dMRI method (Jensen, Russell Glenn, & Helpern, 2016;
Moss, McKinnon, Glenn, Helpern, & Jensen, 2019). FBI offers the ability
to estimate the fiber orientation distribution function (fODF) of white
matter fiber bundles along with related axon-specific microstructural
parameters. This is achieved by using strong diffusion weightings (b-
value > > 2000 s/mm2) to suppress the signal from the more mobile
extra-axonal water pool. Thus, by employing high b-values FBI only
needs to model the intra-axonal compartment, a major advantage of FBI
over other two-compartment models. The main assumption of FBI is that
water diffusion inside axons is accurately described by regarding axons
as thin, straight, impermeable tubes. Compelling experimental evidence
indicates that this is indeed a good approximation at least for myelinated
axons (McKinnon, Jensen, Glenn, & Helpern, 2017; Moss et al., 2019;
Veraart, Fieremans, & Novikov, 2019). Besides the fODF, FBI also allows
estimation of the fractional anisotropy of the intra-axonal space (FAA)
and ζ (a property related to the axonal water fraction; AWF). Fiber ball
white matter modeling (FBWM; McKinnon, Helpern, & Jensen, 2018)
builds upon the principles of FBI but uses both high and low diffusion
weightings to model the extra-axonal space and the intra-axonal space.
FBWM therefore allows the estimation of additional microstructural
parameters including the intrinsic intra-axonal diffusivity (Da), the mean
extra-axonal diffusivity (MDe), the radial (De,⊥) and axial (De,k) extra-
axonal diffusivity, the fractional anisotropy of the extra-axonal space
(FAE), and the AWF (Table 1). FBWM requires more data and more
assumptions than FBI so that there is a natural division between the two.
Specifically, FBWM is built by combining FBI and DKI data. Dis-
tinguishing FBI, DKI, and FBWM parameters emphasizes that they each
have different biophysical underpinnings. FBI and FBWM have not previ-
ously been applied in patient cohorts.
Diffusion tractography provides the ability to reconstruct and
assess diffusion characteristics averaged over whole white matter fiber
bundles and along the longitudinal axis of tracts (along-tract). Along-
tract analysis permits investigation of regionally specific alterations that
may be more sensitive to regional pathology than averaging diffusion
characteristics over entire tracts, particularly as tissue characteristics
vary considerably along white matter tracts (Figure 1). This is particu-
larly important for the in vivo assessment of neuropathology in neuro-
logical disorders as some pathological alterations occur in
circumscribed regions of tracts, which may be overlooked when aver-
aging diffusion metrics over entire tracts (Keller et al., 2017). Along-
tract approaches have demonstrated increased sensitivity for the iden-
tification of diffusion abnormalities in patients with temporal lobe epi-
lepsy (Concha, Kim, Bernasconi, Bernhardt, & Bernasconi, 2012;
Kreilkamp et al., 2019; Kreilkamp, Weber, Richardson, & Keller, 2017),
high levels of sensitivity and specificity for the prediction of postopera-
tive outcome (Keller et al., 2017), and greater yield of diffusion changes
using DKI over conventional DTI (Glenn et al., 2016). The use of FBI
and FBWM combined with along-tract tractography offers the ability
to investigate regional white matter tissue alterations with diffusion
parameters that are biologically specific, which has not previously been
possible using standard DTI approaches.
The modeling of several diffusion parameters with interpretable
biological meaning may offer the development of new, noninvasive
biomarkers of pharmacoresistance in epilepsy. It is unclear why 30%
of patients with focal epilepsy do not attain seizure control despite
anti-epileptic drug (AED) treatment (Kwan & Brodie, 2000). The iden-
tification of a noninvasive imaging biomarker of treatment outcome
would allow earlier stratification to more personalized treatment
methods. However, there have been limited insights into the mecha-
nisms and markers underlying pharmacoresistance using advanced
MRI methods. Markers of hippocampal neuronal-glial changes have
been associated with pharmacoresistance in patients with temporal
lobe epilepsy using MR spectroscopy (Campos et al., 2010; Pimentel-
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Silva et al., 2020). Other studies have reported increased white matter
and gray matter volumetric changes in patients with refractory rela-
tive to nonrefractory focal epilepsy using morphometric techniques
applied to T1-weighted images (Bilevicius et al., 2010; Kim, Kim,
Lee, & Park, 2017), which may relate to differences in functional con-
nectivity between refractory and nonrefractory patients (Pressl
et al., 2019). However, characterization of diffusion properties
between patient groups using advanced methods that offer biological
interpretation has not, to our knowledge, been performed. DTI and
other traditional diffusion imaging methods provide indirect informa-
tion about the underlying cellular microstructure. Diffusion metrics
such as FA and MD represent the diffusion dynamics of all underlying
compartments mixed together. Biophysical models, such as FBWM,
attempt to separate the diffusion dynamics into different compart-
ments (i.e., intra-axonal and extra-axonal) to get a more specific
understanding of changes happening in the underlying microstructure.
This strategy is particularly useful when studying disease processes
that affect microstructural compartments differently and could pro-
vide novel insights into pharmacoresistance in epilepsy.
In the present study, we have investigated intra-axonal and extra-
axonal white matter diffusion alterations in patients with focal epi-
lepsy by combining FBI and FBWM with an along-tract tractography
approach. By specifically recruiting patients with either refractory or
nonrefractory focal epilepsy, we sought to determine whether
changes in the microscopic white matter environment may be a
marker of pharmacoresistance. We expected to find differences
between patient groups in FBI and FBWMmetrics, which have a more
easily understandable biological basis compared to standard DTI.
2 | METHODS
2.1 | Participants
Fifteen adults with focal epilepsy who had responded well to AED
treatment (mean age = 41 years, SD = 12, eight female; hereon
referred to as nonrefractory epilepsy), 15 adults with focal epilepsy
who had refractory epilepsy (mean age = 38 years, SD = 12, eight
TABLE 1 Diffusion parameters determined by FBI and FBWM, their biophysical meanings and potential biological interpretations
Parameters Acronym Meaning Biological interpretation
Axonal water fraction (FBWM) AWF Amount of intra-axonal water divided by the
total amount of MRI-visible water within a
voxel
Decreases if intra-axonal water decreases, if
extra-axonal water increases (edema), or
both
Potential loss of axons, edema
Intra-axonal diffusivity (FBWM) Da Diffusivity of water molecules along the length
of the axons




MDe Mean diffusivity of water within the extra-
axonal compartment. This compartment
includes glial cells and extra-cellular space




De,⊥ Radial diffusivity of the extra-axonal
compartment
Perpendicular to the direction of highest
extra-axonal diffusivity




De,II Axial diffusivity of the extra-axonal
compartment in the direction of highest
extra-axonal diffusivity




FAA The fractional anisotropy of just the water
within of the intra-axonal compartment
Reflects the geometrical arrangement—if all
axons in the same direction, this value is
high
Analogous to regular FA, but typically has
higher values as intra-axonal water is more
organized than extra-axonal water
Extra-axonal fractional anisotropy
(FBWM)
FAE Fractional anisotropy of just the water within
extra-axonal compartment
Analogous to regular FA but typically has
lower values as extra-axonal water is less
organized than intra-axonal water
High values could represent tight packing of
axons
Parameter could be affected by myelination
thickness
Zeta (pure FBI) ζ Equal to the AWF divided by the square root
of the intra-axonal diffusivity (Da)
Scaled version of the AWF
Since Da is often fairly constant across voxels,
ζ is usually strongly correlated with AWF,
but it is easier to measure
Abbreviations: AWF, axonal water fraction; FAA, fractional anisotropy of the intra-axonal; FBWM, fiber ball white matter modeling; FAE, fractional
anisotropy of the extra-axonal.
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female) and 15 healthy controls (mean age = 38 years, SD = 13, seven
female) were recruited into this study. Patients with epilepsy were
recruited from outpatient clinics and clinical databases from the Wal-
ton Centre NHS Foundation Trust in Liverpool, UK. All patients and
controls gave informed consent and ethical approval was given by the
Health Research Authority (UK Research Ethics Committee [REC]
ID = 17/NW/0342; IRAS project ID = 220138). Focal epilepsy was
diagnosed by expert epileptologists based on seizure semiology and
inter-ictal EEG recordings acquired in context of standard clinical care.
Nonrefractory patients had experienced no seizures for at least
6 months prior to recruitment into the study. Refractory patients were
experiencing persistent seizures prior to recruitment. Patients with
primary generalized seizures, nonepileptic seizures, previous neuro-
surgery or known progressive neurological disease were excluded
from this study. A breakdown of all demographic and clinical informa-
tion for patients is provided in Table 2.
2.2 | MR acquisition
All patients and controls were scanned at the Liverpool Magnetic Res-
onance Imaging Centre (LiMRIC) using a 3 T Siemens Prisma MR scan-
ner. Scanning included a T1-weighted magnetization-prepared rapid
acquisition gradient echo sequence (MPRAGE; 192 slices, repetition
time [TR] = 2,000 ms, inversion time [TI] = 912 ms, echo time
[TE] = 2.25 ms, resolution = 1.0 × 1.0 × 1.0 mm3, flip angle = 8,
acquisition time = 7:30 min). In order to calculate FBI and FBWM
parameters, two diffusion-weighted scans were performed: (a) an FBI
sequence (TR = 4,400 ms, TE = 100 ms, 46 axial slices,
resolution = 2.7 × 2.7 × 2.7 mm3, b-values = 0, 5,000 s/mm2,
128 directions) to calculate ζ and FAA; (b) a DKI sequence that was
parameter-matched to the FBI scan (b-values = 0, 1,000, 2000 s/mm2,
30 directions) which, along with the FBI scan, allows for the calcula-
tion of Da, MDe, De,⊥, De,II, FAE, and AWF. A standard DKI scan was
also performed in order to calculate standard DTI metrics of FA and
MD (TR = 3,200 ms, TE = 90 ms, 50 axial slices,
resolution = 2.5 × 2.5 × 2.5 mm3, b-values = 0, 1,000, 2,000 s/mm3,
64 directions).
2.3 | MR preprocessing
dMRI data were preprocessed for scalar map generation (FA, MD,
AWF, Da, FAE, MDe, De,II, De,⊥, FAA, ζ; Table 1) using Matlab Version
R2016b. Preprocessing included MRtrix3 denoizing and Gibbs ringing
removal (Tournier et al., 2019) and correction for Rician noise biases.
FMRIB Software Library (FSL; http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL;
Smith et al., 2004) was used to extract and skull-strip a nondiffusion
weighted (i.e., b = 0) image to generate a “b0” mask. The b0 mask was
binarized and used in FSL eddy current correction to mitigate effects
of image artifacts (Andersson & Sotiropoulos, 2016) and motion cor-
rection, with the b-vectors rotated based in the rigid-body alignment
parameters (Leemans & Jones, 2009). DTI (FA and MD) parameter
maps were generated using diffusional kurtosis estimator (DKE;
F IGURE 1 The advantage of assessing along-tract diffusion metrics over whole tract averaging. (a–d) The left corticospinal tract (shown on
the left in a glass-brain projection for reference) of four subjects in the present study. Averaging a diffusion metric over the entire tract yields the
same mean diffusivity (MD) value (0.87 μm2/ms) for each subject (full red tract). Analysis of MD at 100 points along the length of the
corticospinal tract demonstrates considerable variability in regional MD within and between tracts. TP = tract points

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































BRYANT ET AL. 7
https://www.nitric.org/projects.dke/; Tabesh, Jensen, Ardekani, &
Helpern, 2011) from the standard DKI scan. FBI (FAA and ζ) and
FBWM (AWF, Da, MDe, De,⊥, De,II, and FAE) maps were generated
using in-house Matlab scripts (https://github.com/m-ama/FBWM/)
using the FBI and FBI-matched DKI scans, as previously described
(McKinnon et al., 2018). To prepare data for white matter fiber tract
segmentation, eddy-corrected diffusion images, b0 masks, and b-value
and b-vector files were all normalized to standard Montreal Neurolog-
ical Institute (MNI) space using FSL FLIRT (Greve & Fischl, 2009;
Jenkinson, Bannister, Brady, & Smith, 2002; Jenkinson & Smith, 2001)
and the MNI FA template available in FSL.
2.4 | White matter fiber tract segmentation
Fifty white matter tracts were generated using TractSeg (https://
github.com/MIC-DKFZ/TractSeg/) (Wasserthal, Neher, Hirjak, &
Maier-Hein, 2019; Wasserthal, Neher, & Maier-Hein, 2018) (Figure 2a
and Table 3). TractSeg is a recently developed method for WM tract
segmentation, which shortens typical tractography pipelines by using
a fully convolutional neural network. This method directly segments
white matter tracts in fields of fODF peaks via a fully convolutional
neural network and has been demonstrated to yield more accurate
tract segmentation compared to six other reference methods of
tractography and tract segmentation (Wasserthal et al., 2018).
Tractometry, the final part of the TractSeg pipeline, outputs diffusion
parameter values for 100 points along each segmented white matter
fiber tract which we used for along-tract analysis. The 100 points for
each tract were standardized across participants so that direct com-
parisons for each FBI and FBWM map could be made between groups
(Figure 2b–d).
2.5 | Statistical analysis
TractSeg permitted statistical analysis of FBI and FBWM parameter
values along 100 points of each white matter tract and compared
across three groups: controls, patients with refractory focal epilepsy
and patients with nonrefractory focal epilepsy. Statistical analysis
along-tracts was performed as per the tractometry documentation
available online,1 which is based on the statistical analysis approach
described by Yeatman, Dougherty, Myall, Wandell, and
Feldman (2012). This method uses a permutation based multiple com-
parison correction to appropriately adjust p-values given the correla-
tion structure of the data (Nichols & Holmes, 2002). We adopted this
approach and corrected for age, sex, and multiple comparisons using
family wise error correction. Results were considered significant if the
minimal p-value for each along-tract point was lower than the alpha
value corrected for multiple comparison (Yeatman et al., 2012).
Cohen's d effect sizes were calculated for diffusion parameters and
corrected for small sample size. Effect sizes were plotted along the
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3 | RESULTS
There was no significant difference between refractory and non-
refractory groups in the number of patients with (refractory = 9, 60%;
nonrefractory = 10, 67%) and without (refractory = 6, 40%; non-
refractory = 5, 33%) radiologically diagnosed lesions that were
considered to be not incidental (Table 2; χ2 = 0.14, p = .70). There was
no significant difference in age (t = 0.62, p = .54), age of onset of epi-
lepsy (t = 0.02, p = .99) or duration of epilepsy (t = 0.71, p = .54)
between refractory and nonrefractory patient groups.
All significant differences in FBI and FBWM parameters between
patients with refractory epilepsy, nonrefractory epilepsy and controls
F IGURE 2 (a) White matter tracts automatically segmented using TractSeg included in the present study. See Table 3 for definition of
abbreviations. (b) Illustration of group comparisons of FBWM maps for along-tract analyses. (c) Visualization of Cohen's d effect sizes computed
along the length of an exemplar tract (ATR; see a) that is significantly different between two groups. (d) Mean (±SEM) diffusion values are plotted
for each point along the tract. P < αFWE: region along the tract where the p value is smaller than the αFWE and considered statistically
significant. TP = tract points
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are tabulated in Table 4. Significant differences between patients with
refractory epilepsy and controls are illustrated in Figure 3. Significant
differences were observed for seven diffusion measures over 12 tracts
and effect sizes for significantly different regions were large (d = ±1 or
greater). Inspection of the along-tract values for both groups demon-
strate that refractory patients showed consistent diffusion alterations
over the entire length of tracts and statistical analysis revealed only
the peak difference between groups. In putative measures of intra-
axonal diffusivity, patients with refractory epilepsy had significantly
reduced AWF in a region of the left striatoprefrontal tract (ST PREM)
and reduced ζ in regions of the right cingulum (CG), right inferior lon-
gitudinal fascicule (ILF), right superior longitudinal fascicle segment III
(SLF III), and right uncinate fascicle (UF) relative to controls. Increased
ζ was seen in a region of the right inferior cerebellar peduncle (ICP).
There were more widespread changes in putative measures of extra-
axonal diffusivity, including increases in MDe and De,II in regions of
the right ICP, left superior cerebellar peduncle (SCP), and in the left ST
PREM in De,II only. Additional De,⊥ increases were observed in the
right arcuate fascicle (AF), left anterior thalamic radiation (ATR), left
frontopontine tract (FPT), and left and right ICP. Significantly
increased FAA and FAE was also observed within the right ICP in
refractory patients compared to controls.
Significant differences in FBI and FBWM parameters between
patients with nonrefractory epilepsy and controls are illustrated in
Figure 4. Patients with nonrefractory epilepsy showed substantially
fewer diffusion alterations and smaller effect sizes. Significant differ-
ences were observed for six diffusion measures over six tracts.
Patients had significantly increased values of the following parameters
compared to controls: Da in a region of the left superior thalamic radi-
ations (STR), De,II of the right thalamoparietal (T PAR) and right
thalamo-occipital (T OCC) tracts, increased De,⊥ of the left ATR and
left thalamopremotor (T PREM) tracts, and FAA of the right STR.
In direct comparisons between patient groups, patients with
refractory epilepsy showed evidence of significantly increased puta-
tive measures of extra-axonal diffusivity compared to patients with
nonrefractory epilepsy (Figure 5). These were manifest as significantly
increased MDe in regions within the right corticospinal tract (CST) and
right ICP, increased De,II in right ICP, and increased De,⊥ in regions of
the left FPT, right and right ICP. Patients with refractory epilepsy also
had significantly increased ζ in regions of the middle cerebellar pedun-
cle (MCP) and right SCP. Significantly reduced FAA was observed in
regions of the left optic radiation (OR) and left T OCC in refractory
patients.
Analysis of conventional DTI metrics showed limited and more
spatially restricted diffusion changes. There were no significant differ-
ences in FA or MD between refractory patients and controls. Non-
refractory patients had significantly decreased FA in the rostrum of
the corpus callosum (CC1) and increased MD in a region of the left
ATR compared to controls (Figure 4). Direct comparisons between
patient groups revealed significantly reduced FA in nonrefractory
patients in the right SCP and increased MD in refractory patients in
regions of the right CST, left FPT, right ICP, left and right parieto-
occipital pontine tracts (POPTs) (Figure 5).
4 | DISCUSSION
This study is the first to apply FBI and FBWM to a clinical population.
We have used this advanced dMRI method together with along-tract
tractography to investigate white matter microstructural changes in
patients with longstanding focal epilepsy. By using FBI and FBWM,
we are able make inferences about the biological processes underlying
tissue diffusion changes, which has previously been difficult to do
using conventional DTI. As expected, we found differences between
patient groups and controls, and in accordance with previous litera-
ture we found increases in diffusivity parameters in patient groups.
Relative to controls, refractory patients had significant increases in
the putatative extra-axonal measures of MDe, De,II, and De,⊥ across
several WM tracts. Conversely, patients with nonrefractory epilepsy
had limited statistically significant increases in extra-axonal diffusion
TABLE 3 White matter tracts analyzed in the present study; see
Figure 2
AF Arcuate fascicle
ATR Anterior thalamic radiation
CC1 Corpus callosum: Rostrum
CC2 Corpus callosum: Genu
CC3 Corpus callosum: Rostral body, premotor
CC4 Corpus callosum: Anterior midbody, primary motor
CC5 Corpus callosum: Posterior midbody, primary
somatosensory
CC6 Corpus callosum: Isthmus




ICP Inferior cerebellar peduncle
IFO Inferior occipitofrontal fascicle
ILF Inferior longitudinal fascicle
MCP Middle cerebellar peduncle
OR Optic radiation
POPT Parieto-occipital pontine
SCP Superior cerebellar peduncle
SLFI Superior longitudinal fascicle segment I
SFLII Superior longitudinal fascicle segment II
SLFIII Superior longitudinal fascicle segment III
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TABLE 4 Fiber ball white matter modeling (FBWM) significant differences between patients with refractory epilepsy, nonrefractory epilepsy
and controls
Parameters Tract Controls Refractory αFWE Min p-value t-value Cohen's d
AWF L ST PREM 0.56 (0.04) 0.50 (0.07) 0.001125 .000537 −3.91 1.39
FAE R ICP 0.18 (0.10) 0.26 (0.10) 0.002152 .001075 3.65 −1.30
MDe R ICP 0.97 (0.20) 1.39 (0.45) 0.002295 7.40E-05 4.64 −1.65
L SCP 1.17 (0.13) 1.45 (0.23) 0.000558 .000292 4.14 −1.47
De,II R ICP 1.30 (0.26) 1.82 (0.61) 0.002143 .00017 4.34 −1.54
L SCP 1.76 (0.26) 2.22 (0.39) 0.000665 .000386 4.03 −1.43
L ST PREM 1.36 (0.10) 1.56 (0.20) 0.001006 .000451 3.97 −1.41
De,⊥ R AF 0.74 (0.05) 0.83 (0.08) 0.000969 .000503 3.93 −1.40
L ATR 0.77 (0.03) 0.82 (0.05) 0.001134 .000104 4.52 −1.61
L FPT 0.71 (0.05) 0.79 (0.07) 0.000745 3.70E-05 4.89 −1.74
L ICP 0.71 (0.08) 0.87 (0.19) 0.002178 .001242 3.59 −1.28
R ICP 0.81 (0.18) 1.17 (0.39) 0.00254 5.00E-05 4.79 −1.70
L T PREM 0.74 (0.02) 0.79 (0.05) 0.000724 .000315 4.11 −1.46
FAA R ICP 0.28 (0.14) 0.48 (0.07) 0.002887 2.00E-06 6.03 −2.14
ζ R CG 0.32 (0.02) 0.29 (0.02) 0.000618 .000516 −3.92 1.39
R ICP 0.15 (0.08) 0.21 (0.05) 0.002866 .000377 4.04 −1.44
R ILF 0.24 (0.03) 0.19 (0.03) 0.000944 .000479 −3.95 1.40
R SLF III 0.39 (0.02) 0.36 (0.02) 0.000781 .000219 −4.24 1.51
R UF 0.23 (0.03) 0.18 (0.03) 0.001022 .000909 −3.71 1.32
Controls Nonrefractory
Da L STR 2.10 (0.27) 2.50 (0.31) 6.00E-04 .000565 −3.89 1.38
De,II R T PAR 1.18 (0.05) 1.30 (0.10) 0.000451 .000163 −4.35 1.55
R T OCC 1.21 (0.06) 1.37 (0.13) 0.000484 .000171 −4.33 1.54
De,⊥ L ATR 0.76 (0.03) 0.85 (0.06) 0.000758 3.00E-06 −5.81 2.06
L T PREM 0.69 (0.03) 0.75 (0.04) 0.000754 .000199 −4.28 1.52
FA CC1 0.37 (0.04) 0.31 (0.05) 0.002028 .000699 3.81 −1.35
FAA R STR 0.61 (0.02) 0.65 (0.03) 0.000539 .000229 −4.23 1.50
MD L ATR 0.91 (0.05) 0.98 (0.04) 0.000683 .000113 −4.48 1.59
Refractory Nonrefractory
MDe R CST 1.11 (0.07) 1.02 (0.05) 0.001903 .001867 3.44 −1.22
R ICP 1.36 (0.13) 1.17 (0.21) 0.001822 .000732 3.79 −1.35
De,II R ICP 1.86 (0.20) 1.63 (0.25) 0.003316 .001363 3.56 −1.26
De,⊥ L FPT 0.79 (0.05) 0.71 (0.03) 0.000809 5.60E-05 4.74 −1.69
R ICP 1.11 (0.17) 0.94 (0.23) 0.002599 .000789 3.76 −1.34
FA R SCP 0.44 (0.05) 0.37 (0.05) 0.003208 .001382 3.55 −1.26
FAA L OR 0.63 (0.03) 0.67 (0.03) 0.000264 .000237 −4.21 1.50
L T OCC 0.62 (0.02) 0.67 (0.03) 0.000253 .00011 −4.50 1.60
MD R CST 1.14 (0.08) 1.01 (0.08) 0.00058 1.10E-05 5.33 −1.89
L FPT 1.04 (0.05) 0.93 (0.05) 0.000512 1.90E-05 5.15 −1.83
R ICP 1.13 (0.09) 1.04 (0.12) 0.003937 .002445 3.33 −1.18
L POPT 1.08 (0.08) 0.96 (0.08) 0.000644 .00013 4.43 −1.58
R POPT 1.22 (0.11) 1.05 (0.10) 0.000544 8.40E-05 4.59 −1.63
ζ MCP 0.44 (0.05) 0.36 (0.07) 0.005229 .001876 3.43 −1.22
R SCP 0.32 (0.05) 0.26 (0.06) 0.003404 .001244 3.59 −1.28
Note: The mean (SD) of the individual diffusion parameter, minimum p-value and its corresponding α value, t statistic, and Cohen's d for the peak of each
significant tract are provided. Diffusivities are expressed in units of μm2/ms, while ζ values are in units of ms1/2/ μm; all other quantities are dimensionless.
Abbreviations for parameters are provided in Table 1 and for tracts in Table 3.
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F IGURE 3 Statistically significant (red peaks) along-tract differences in FBWM diffusion properties in refractory patients compared to
controls. 3D plots show Cohen's d values projected onto the relevant tracts with significant region highlighted by red boxes. Effect sizes greater
than and equal to 1 are shown in dark red, with those less than and equal to −1 shown in dark blue. Significantly different ζ in regions of the right
SLF III and right UF not illustrated (see Table 4). Diffusivities are expressed in units of μm2/ms, while ζ values are in units of ms1/2/μm; all other
quantities are dimensionless. TP = tract points
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measures compared to controls; this contrast in extra-axonal diffusion
between patient groups was exemplified in direct comparisons, which
demonstrated significantly greater measures of extra-axonal diffusion
in refractory patients. Analysis of FBI and FBWM diffusion measures
was substantially more revealing than conventional DTI metrics. We
discuss the biological and clinical significance of these findings before
highlighting pertinent methodological issues.
4.1 | Biological and clinical implications
The FBI/FBWM two compartment model permits separation of intra-
axonal and extra-axonal water diffusion. MDe is a measure of extra-
axonal diffusivity, which is similar to MD but only for the extra-axonal
diffusion compartment. Similarly, De,⊥ is analogous to RD using con-
ventional DTI, but for the extra-axonal compartment. An increase in
extra-axonal space has been argued to reflect an increase in neu-
roinflammation via microglial activation (Pasternak et al., 2012;
Schwartz, Butovsky, Bruck, & Hanisch, 2006). Neuroinflammation is
known to have an important role in epilepsy (Amhaoul, Staelens, &
Dedeurwaerdere, 2014). Neuroinflammation has been studied exten-
sively using positron emission tomography (PET), specifically using the
radioligands (R)-[11C]PK11195 and 18F-PBR111 as measures of
translocator protein (TSPO), which is upregulated in the context of
activated glial cells (Scott, Mahmud, Owen, & Johnson, 2017). PET-
derived measures of neuroinflammation have been validated in rat
models of TLE—kainic acid-induced status epilepticus—where
increased TSPO expression has been associated with increased
F IGURE 4 Statistically significant (red peaks) along-tract differences in FBWM diffusion properties in nonrefractory patients relative to
controls. 3D plots show Cohen's d values projected onto the relevant tracts with significant region highlighted by red boxes. Effect sizes greater
than and equal to 1 are shown in dark red, with those less than and equal to −1 shown in dark blue. Diffusivities are expressed in units of μm2/
ms, while ζ values are in units of ms1/2/μm; all other quantities are dimensionless. TP = tract points
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F IGURE 5 Statistically significant (red peaks) along-tract differences in FBWM diffusion properties in refractory patients relative to
nonrefractory patients. 3D plots show Cohen's d values projected onto the relevant tracts with significant region highlighted by red boxes. Effect
sizes greater than and equal to 1 are shown in dark red, with those less than and equal to −1 shown in dark blue. Diffusivities are expressed in
units of μm2/ms, while ζ values are in units of ms1/2/μm; all other quantities are dimensionless. TP = tract points
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microglial activation determined using immunohistochemistry
(Amhaoul et al., 2015). In people with well circumscribed and phe-
notyped focal epilepsy, neuroinflammatory changes have been dem-
onstrated in regions beyond the presumed seizure focus. For example,
increased TSPO uptake has been demonstrated in temporal and
extra-temporal lobe regions, ipsilateral and contralateral to the pre-
sumed seizure focus, in patients with TLE (Gershen et al., 2015;
Hirvonen et al., 2012). Increased neuroinflammatory changes have
been reported in a case study of post-ictal human focal epilepsy using
PET (Butler et al., 2016). Interestingly, previous work has demon-
strated increased uptake of (R)-[11C]PK11195 in rats with persistent
seizures despite phenobarbital treatment compared to rats that
responded well to treatment (Bogdanovic et al., 2014). Taken
together, these findings suggest that neuroinflammatory changes in
local and distal brain regions are associated with refractory seizures,
which may be considered consistent with the widespread extra-axonal
water diffusion changes observed in the present study. Given that we
preferentially observed increased extra-axonal diffusion in refractory
patients, we suggest that imaging measures sensitive to the extra-
axonal space may be a biomarker of pharmacoresistance. However, in
human epilepsy studies, it is difficult to discern whether increased
extra-axonal space and/or neuroinflammatory processes are a cause
or consequence of active seizures. Nevertheless, it is interesting that
patients with nonrefractory epilepsy who had not experienced sei-
zures for an average of over 3 years (Table 2) also showed evidence
of more restricted pattern of extra-axonal diffusion compared to con-
trols (Figure 4).
An alternative explanation is that increased extra-axonal space is
directly due to axonal degeneration (Rodriguez-Cruces &
Concha, 2015). Reduced myelin content and axonal density of myelin-
ated and nonmyelinated axons has been reported in refractory focal
epilepsy (Garbelli et al., 2012), and reduced cumulative axonal mem-
brane circumference is associated with reduced FA in WM tracts in
close proximity to the epileptogenic zone (Concha et al., 2010).
Reduced axonal density inherently generates increased extra-axonal
space (Rodriguez-Cruces & Concha, 2015), and this process could be
driving increased extra-axonal diffusion in patients with epilepsy.
Most studies examining axonal density in refractory focal epilepsy
naturally restrict analysis to the presumed epileptogenic zone (given
the opportunity to perform histological studies on resected speci-
mens). Whether the same neuropathology extends to axons extending
distally across the brain as we have shown here is a more contentious
issue. We report extra-axonal diffusivity alterations across many WM
tracts that are presumably not part of the epileptogenic zone. The
underlying histological cause of these changes remain unknown.
We additionally report increases in regional white matter MD in
patients with refractory epilepsy compared to those with non-
refractory epilepsy. MD is a measure of all diffusion which is
directionally averaged and may in itself be a marker of cellularity,
edema and necrosis (Alexander et al., 2011). Increased MD is often
reported in many dMRI studies of epilepsy (Concha, Beaulieu, Col-
lins, & Gross, 2009; Jiang et al., 2017; McDonald et al., 2008). More-
over, MD was found to be superior to other conventional diffusion
metrics in predicting postoperative seizure outcome from preopera-
tive DTI in patients with TLE (Keller et al., 2017). The results pres-
ented here suggest that the previously widespread observed changes
in WM diffusivity using conventional DTI in patients with refractory
focal epilepsy are largely driven by the extra-axonal diffusivity
component.
4.2 | Methodological considerations
While FBI and FBWM are recently developed techniques that had not
been previously applied to clinical populations, other dMRI two
−/multicompartment models have been employed in clinical contexts
to further understand the cerebral microstructural environment. Free-
water imaging approaches have been proposed for detecting neuro-
inflammatory markers in disorders known to have neuroinflammatory
components including schizophrenia (Pasternak et al., 2012),
Parkinson's disease (Planetta et al., 2016), and concussion (Pasternak
et al., 2014). Neurite orientation dispersion and density imaging
(NODDI) (Zhang, Schneider, Wheeler-Kingshott, & Alexander, 2012)
has been used to demonstrate alterations in intracellular volume frac-
tion, a marker of neurite density, in malformed brain regions causing
epilepsy (Winston et al., 2014) and in widespread temporal and
extratemporal brain regions in TLE (Winston et al., 2020). Other work
has reported that NODDI-derived orientation dispersion index maps
reveal cortical and subcortical abnormalities in patients with non-
lesional focal epilepsy (Rostampour, Hashemi, Najibi, &
Oghabian, 2018). Multicompartment models are better able to under-
stand the biological processes driving changes in diffusion parameters
(Winston et al., 2020). By modeling diffusion with two
−/multicompartment models, evidence suggests that improved detec-
tion of focal abnormalities and further insights into the underlying
microstructure of the brain is possible. While these models have pro-
vided important insights into microstructural brain changes associated
with neuropathology, there are notable issues with many dMRI tissue
models. These include problems with nonlinear fitting algorithms, on
which many of these models are based, which can lead to increased
computational times, sensitivity to noise and imaging artifacts, and
issues related to the accuracy of the underlying idealizations (Novikov
et al., 2018). FBWM mitigates these difficulties with a two-
compartment model based on well-supported assumptions and a sim-
ple computational scheme involving a straightforward linear transfor-
mation of the dMRI signal together with a one-dimensional numerical
optimization. Further, FBWM improves substantially upon the white
matter tract integrity (WMTI) method (Fieremans et al., 2011). The
WMTI method (Fieremans et al., 2011) assumes that all axons in a
given voxel are approximately aligned in the same direction, which
creates issues in regions of crossing fibers. FBWM overcomes this by
using the fODF from FBI rather than assuming a particular geometric
arrangement of axons and, as such, should more accurately model
regions with crossing fibers.
Rather than averaging diffusion metrics over each reconstructed
white matter tract we chose to utilize an along-tract approach. Given
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that white matter tissue diffusional characteristics vary long the
length of tracts, it is advantageous to capture this variation in clinical
studies as averaging across whole tracts may obscure regionally spe-
cific and pathologically relevant diffusion alterations (Figure 1). This is
especially important for the development of imaging markers of treat-
ment outcome in epilepsy; only by quantifying diffusion changes along
tracts did a previous study identify preoperative markers of excellent
and suboptimal postoperative seizure outcomes in patients with
refractory TLE (Keller et al., 2017). In the present study, we were able
to identify the circumscribed region of principle difference in extra-
axonal diffusivity within tracts between patient groups and controls.
Moreover, given the inconsistent regional differences in diffusion
metrics within tracts between refractory and nonrefractory patients
(Figure 5), we would be unable to identify significant differences in
tract characteristics if diffusion measures were averaged over the
entire tracts. In order to further improve upon this method, future
work could make use of the fODFs generated directly from FBI. These
are expected to yield improved tractography results over fODFs from
standard DTI (Jensen et al., 2016; Moss et al., 2019). Our data suggest
that dMRI two-compartment models analyzed over the length of
tracts may be a noninvasive marker of pharmacoresistance in patients
with epilepsy. It is possible to use alternative image analysis tech-
niques to examine microstructural properties of white matter path-
ways, such as tract-based spatial statistics (TBSS). TBSS offers the
opportunity to perform voxel-based analyses of representative
regions while minimizing multiple comparisons by evaluating voxels
constrained to a core white matter skeleton in standard space. How-
ever, we chose to apply a tractography approach that offers increased
patient-constrained neuroanatomical precision and permits compre-
hensive profiling of microstructural properties along full white matter
tracts, which we suggest may provide the best opportunity to identify
individualistic diffusion-based biomarkers of treatment outcome
(Keller et al., 2017). Finally, despite that this application of FBI and
FBWM modeling is the first in a clinical cohort and has demonstrated
robust extra-axonal alterations in patients recruited according to
treatment response, it has done so in a modest sized cohort. Further
insights into treatment response and patient cognitive profiles may be
achieved in larger prospective studies.
5 | CONCLUSIONS
This is the first clinical application of FBI and FBWM. The two-
compartment diffusion model has provided the means to separate
intra-axonal and extra-axonal diffusion alterations in patients with
longstanding epilepsy. The strongest findings were with parameters
sensitive to extra-axonal diffusion, which may suggest significant
neuroinflammatory processes and/or axonal degeneration. This
work demonstrates that these changes are more widespread in
patients with refractory epilepsy compared to those with well-
controlled seizures located along eloquent white matter tracts not
considered to be part of the epileptogenic zone in patients with
focal seizures.
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